Authors
Loading...
This analysis reveals potential drawbacks of AAV vectors in gene therapy and cellular reprogramming, emphasizing critical limitations in iPSC engineering.
abdelnaby et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: